Prior authorization and notification requirements for DME, procedures, and related services
Lists services, durable medical equipment (DME), procedures and items that require prior authorization or notification for Harvard Pilgrim/Point32Health (applies to providers submitting claims and arranging prior authorizations). Includes references to CMS and MassHealth criteria used for determinations.
Table 4 was added to list specific drugs/therapies and their procedure codes and Medicare criteria references.
Therapeutic CGM category and associated codes E2102 and A4238 were updated.
Notification and prior authorization lists were reorganized and SCO PA and SCO Notification lists combined into one MNG.
Coding updates were made for multiple specialty drugs (e.g., Zynteglo J3393, Lyfgenia J3394, Amtagvi added).
CAR-T administration codes prior authorization was removed.
Added multiple services to prior authorization (e.g., Intensity Modulated Radiation Therapy, Proton Beam Therapy, various surgical procedures, genetic testing) and added codes to prior authorization under Power Mobility Devices.
Updated hypoglossal nerve stimulator coding — added 64582, 64583, 64584 and removed 64568, 0466T, 0467T, 0468T.
Removed prior authorization from CAR-T administration codes and from multiple IMRT and varicose vein codes retroactive to January 1, 2025.
Added new HCPCS/CPT codes to PA under upper limb prostheses and other tables (e.g., L6028-L6033, L6037, L6700, L7406; later L6034-L6039) effective April 1, 2025 and October 1, 2025 respectively.
Removed about 147 codes from prior authorization associated with standard prosthetic builds, moving services to covered and focusing PA on myoelectric and complex components, effective February 1, 2026.
Intensity-Modulated Radiation Therapy removed from table 1 due to CMS end-dating of codes 77385, 77386, G6015, G6016; related CPT recoding performed.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.